|
|
methyl phosphonamidite
Methyl Phosphonamidites may be used in DNA synthesizers following conventional CE Phosphoramidite protocols to produce oligonucleotides containing one or more methyl phosphonate linkages. However, deprotection and purification techniques differ and a description of the procedures is included with each delivery of these monomers. We also offer the dC monomer with acetyl base protection.1 This protecting group is removed with ammonium hydroxide during the cleavage step, eliminating modification at the dC sites during the deprotection step using ethylenediamine in ethanol.
| 10-1100-02 |
0.25g |
50.00 |
| |
10-1100-05 |
0.5g |
100.00 |
| 10-1115-02 |
0.25g |
50.00 |
| |
10-1115-05 |
0.5g |
100.00 |
| 10-1120-02 |
0.25g |
50.00 |
| |
10-1120-05 |
0.5g |
100.00 |
| 10-1130-02 |
0.25g |
50.00 |
| |
10-1130-05 |
0.5g |
100.00 |
|
REFERENCE
(1) M.P. Reddy, F. Farooqui, and N.B. Hanna, Tetrahedron
Lett., 1996, 37, 8691-8694.
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
|
PACE phosphoramidites
Phosphonoacetate (PACE) modified oligonucleotides show great potential as biological modifiers in a wide variety of research applications. PACE monomers are part of a family of Phosphonocarboxylate monomers. The monomers can be easily incorporated into complex oligonucleotides and are compatible with a wide variety of other sugar or heterobase modifications. PACE DNA can be conjugated through the carboxylic acid functional group. They have been shown to be active in siRNA duplexes and accelerate the initial rate of cleavage by RNase H-1 when incorporated with phosphorothioates. However, the most interesting observation to date is that they exhibit an unprecedented enhancement in penetration of cultured cells.
The phosphonoacetates are fully soluble in acetonitrile at a recommended concentration of 0.1M and are compatible with standard DNA synthesizers. A recommended coupling time of 33.3 minutes with 1H-Tetrazole is necessary when using the standard protocol. A modified LV cycle for AB instruments that reduces coupling time to 15 minutes with 1H-Tetrazole is available on our website. Oxidation must precede capping in the synthesis cycle. Reagents for oxidation depend on the type of synthesis. For fully modified oligos, we recommend the non-aqueous oxidizer camphorsulfonyloxaziridine (CSO) as a 0.1M solution. For mixed phosphodiester and phosphonoacetate modified oligos, a 0.5M CSO solution with a minimum oxidation time of 3 minutes is recommended. Low water oxidizer, 40-4032, is an alternative oxidizing reagent although it has been reported that this can result in conversion of a small percentage of the phosphonoacetate to the phosphodiester. We also recommend the use of the Cap Mix B with DMAP (40-4020) instead of the standard Cap Mix B containing 1-Methylimidazole.
The standard protocol for cleavage and deprotection requires a two step method with pretreatment using 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) and subsequent cleavage using methylamine. The DBU is used to deprotect the dimethylcyanoethyl (DMCE) protecting groups and to prevent alkylation of the bases during deprotection. Cleavage with 40% methylamine in water is recommended and we have also had good results when using AMA deprotection.
| 10-1140-02 | 0.25g | 100.00 |
| | 10-1140-05 | 0.5g | 200.00 |
| | 10-1140-10 | 1.0g | 400.00 |
| 10-1150-02 | 0.25g | 100.00 |
| | 10-1150-05 | 0.5g | 200.00 |
| | 10-1150-10 | 1.0g | 400.00 |
| 10-1160-02 | 0.25g | 100.00 |
| | 10-1160-05 | 0.5g | 200.00 |
| | 10-1160-10 | .0g | 400.00 |
| 10-1170-02 | 0.25g | 100.00 |
| | 10-1170-05 | 0.5g | 200.00 |
| | 10-1170-10 | 1.0g | 400.00 |
|
0.1M CSO in Anhydrous Acetonitrile (ABI) | 40-4631-52 |
200mL |
85.00 |
| 0.1M CSO in Anhydrous Acetonitrile (Expedite) |
40-4631-52E |
200mL |
85.00 |
|
INTELLECTUAL PROPERTY
These products are covered by patents, US 6,693,187 and 7,067,641, and patents pending owned by Metasense Technologies. Purchase of all or any of these products includes a limited license to use the products solely for the manufacture of oligonucleotides for research use only. This license specifically excludes the use of the product or oligonucleotides containing the product for: (a) therapeutic or diagnostic applications (including kits, pools, libraries and other products or services that incorporate oligonucleotides containing the product), (b) any in vivo toxicity/safety study in support of an investigational new drug application (or foreign counterpart), or (c) resale (including sale of kits, pools, libraries and other products or services that incorporate the product or oligonucleotides containing the product). If such activities have commercial application, a separate license is required from Metasense Technologies. Neither the product nor any product created through its use may be used in human clinical trials.
A simple agreement must be signed before end-users and custom oligo services may purchase these products for use as defined above.
http://www.glenres.com/Reference/PACE.pdf
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
ALSO SEE
0.5M CSO p32 |
methyl phosphoramidites
For many years, Glen Research has supplied methyl phosphoramidites
in addition to þ-cyanoethyl (CE) phosphoramidites for the few situations
where the more labile cyanoethyl group is not an advantage. Some of our
customers, probably remembering that the methyl group was removed specifically
with thiophenol, have tried to use these monomers to prepare the interesting,
uncharged, and nuclease-resistant methyl phosphotriester linkage. Unfortunately,
this linkage is labile to ammonium hydroxide and the regular phosphodiester
linkage is formed (along with a small amount of chain scission). Now we
offer UltraMild methyl phosphoramidites for this application. Oligos produced
from these monomers can be deprotected with potassium carbonate in methanol
to produce methyl phosphotriester linkages. Since these linkages are diastereomeric
and uncharged, the oligos may be hard to handle. Consequently, it is likely
that chimeras will be produced using these monomers along with the regular
UltraMild CE phosphoramidites. If many dG residues are included in the
oligonucleotide, we recommend the use of phenoxyacetic anhydride (PAc2O)
in Cap A. This modification removes the possibility of exchange of the
isopropyl-phenoxyacetate (iPr-Pac) protecting group on the dG with acetate
from the acetic anhydride capping mix.
| 10-1301-02 |
0.25g |
25.00 |
| |
10-1301-05 |
0.5g |
50.00 |
| |
10-1301-10 |
1.0g |
100.00 |
| 10-1315-02 |
0.25g |
25.00 |
| |
10-1315-05 |
0.5g |
50.00 |
| |
10-1315-10 |
1.0g |
100.00 |
| 10-1321-02 |
0.25g |
25.00 |
| |
10-1321-05 |
0.5g |
50.00 |
| |
10-1321-10 |
1.0g |
100.00 |
| 10-1330-02 |
0.25g |
25.00 |
| |
10-1330-05 |
0.5g |
50.00 |
| |
10-1330-10 |
1.0g |
100.00 |
|
ULTRAMILD SOLVENTS/REAGENTS
| 40-4210-52 | 200mL |
140.00 |
| (Applied Biosystems) |
40-4210-57 | 450mL |
300.00 |
| 40-4212-52 | 200mL |
140.00 |
| (Expedite) | 40-4212-57 | 450mL |
300.00 |
| 60-4600-30 | 30mL | 30.00 | | |
h-phosphonate monomers
Glen Research H-Phosphonates are analyzed by HPLC and are
synthesis-tested. H-Phosphonates are especially useful for the preparation
of modified internucleotide linkages which are unattainable by phosphoramidite
chemistry. The most popular application is the preparation of radiolabelled
phosphorothioates, since the sulfurization reaction is carried out off
the synthesizer. These monomers are packaged in ABI-style vials (see note
box).
| 10-1200-02 |
0.25g |
40.00 |
| |
10-1200-05 |
0.5g |
80.00 |
| 10-1210-02 |
0.25g |
40.00 |
| |
10-1210-05 |
0.5g |
80.00 |
| 10-1220-02 |
0.25g |
40.00 |
| |
10-1220-05 |
0.5g |
80.00 |
| 10-1230-02 |
0.25g |
40.00 |
| |
10-1230-05 |
0.5g |
80.00 |
|
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
|
Please inquire for availability
of columns for other
instrument types. |
ABBREVIATIONS
I2 = Iodine
TEA = Triethylamine
THF = Tetrahydrofuran
|
h-phosphonate reagents
All solvents and reagents are prepared to our exacting specifications
to ensure the highest coupling efficiencies and are passed through a 0.2
micron filter during packaging to eliminate particulate contamination.
| (Activator for monomers
and capping reagent) |
| 40-4550-50 |
100mL |
24.00 |
| (Diluent) |
| 40-4551-50 |
100mL |
24.00 |
| (Diluent) |
| 40-4510-45 |
45mL |
36.00 |
| (Capping Reagent) |
| 40-4500-51 |
150mL |
28.00 |
| (Neutralizer) |
| 40-4500-60 |
960mL |
120.00 |
| (Wash Solvent) |
| 40-4531-45 |
45mL |
|
| 40-4532-45 |
45mL |
|
| (*
This item has been discontinued.) |
|
THIOPHOSPHORAMIDITES
Replacing two non-bridging oxygen atoms with sulfur atoms in a DNA phosphodiester linkage creates a phosphorodithioate (PS2) linkage.1 Like natural DNA, the phosphorodithioate linkage is achiral at phosphorus. This analog is completely resistant to nuclease degradation and forms complexes with DNA and RNA with somewhat reduced stabilities.2 Moreover, it has been found that PS2-ODNs bind proteins with a higher affinity than their phosphodiester analogues2-6 suggesting that PS2-ODNs may have additional utility in the form of sulfur-modified phosphate ester aptamers (thioaptamers)3,6-8 for therapeutic and diagnostic applications. Thiophosphoramidites are now commercially available after recent work at AM Biotechnologies (www.thioaptamer.com).
- Thiophosphoramidites (ThioPAs) are not soluble in anhydrous acetonitrile diluent. Rather, 10% DCM (v/v) in acetonitrile is an ideal diluent for all four of the thioPAs for a final amidite concentration of 0.15 M.
- ThioPAs are somewhat less stable than normal DNA phosphoramidites in anhydrous acetonitrile containing 10% DCM; however, the coupling efficiency of all four thioPAs is not reduced after two days in solution at room temperature.
- After synthesis, the thioPA bottle on the synthesizer should be replaced with one containing acetonitrile diluent and the synthesizer line flushed with acetonitrile.
A typical cycle for the solid-phase synthesis of a PS2 linkage is different from a standard cycle for the synthesis of normal phosphate linkages. After coupling, the resulting thiophosphite triester is then sulfurized with DDTT. Capping is carried out AFTER sulfurization.
Upon completion of the automated synthesis, deprotection is carried out using a concentrated ammonia:ethanol (3:1, v:v) mix containing 20 mM DTT at 55 °C for 15-16 h.
| 10-1700-90 | 100 µmole | 150.00 |
| 10-1700-02 | 0.25g | 360.00 |
| 10-1710-90 | 100 µmole | 150.00 |
| 10-1710-02 | 0.25g | 360.00 |
| 10-1720-90 | 100 µmole | 150.00 |
| 10-1720-02 | 0.25g | 360.00 |
| 10-1730-90 | 100 µmole | 150.00 |
| 10-1730-02 | 0.25g | 360.00 |
| REFERENCES
(1) J. Nielsen, W.K.D. Brill, and M.H. Caruthers, Tetrahedron Letters, 1988, 29, 2911-2914.
(2) L. Cummins, D. Graff, G. Beaton, W.S. Marshall, and M.H. Caruthers, Biochemistry, 1996, 35, 8734-41.
(3) X. Yang, and D.G. Gorenstein, Curr Drug Targets, 2004, 5, 705-15.
(4) W.S. Marshall, and M.H. Caruthers, Science, 1993, 259, 1564-70.
(5) J.L. Tonkinson, et al., Antisense Research and Development, 1994, 4, 269-278.
(6) X. Yang, et al., Bioorg Med Chem Lett, 1999, 9, 3357-62.
(7) X. Yang, et al., Ann N Y Acad Sci, 2006, 1082, 116-9.
(8) X. Yang, et al., Nucleic Acids Res, 2002, 30, e132.
(9) W.T. Wiesler, W.S. Marshall, and M.H. Caruthers, Methods Mol Biol, 1993, 20, 191-206. |
sulfurizing reagent
Glen Research’s Sulfurizing Reagents are used to prepare phosphorothioate linkages using CE phosphoramidite chemistry. Each reagent exhibits the following attributes:
1) Reliably soluble, making them safe to use on automated synthesizers.
2) Reaction is fast (30 seconds), making the process convenient on small scales and readily amenable to scale-up.
3) Process is efficient, with better than 96% of the linkages being phosphorothioate and the remainder being phosphodiester.
When ordering Sulfurizing Reagent (Beaucage Reagent), please also order the silanized bottle appropriate for your instrument. There will be no charge for one bottle when supplied with a reagent order. The silanized bottle can be reused after rinsing with acetonitrile and drying. Additional silanized bottles are priced as shown below. Dissolve the reagent in acetonitrile at a concentration of 1g/100mL.
Sulfurizing Reagent II (3-((Dimethylamino-methylidene)amino)-3H-1,2,4-dithiazole-3-thione, DDTT) exhibits all the properties of Beaucage Reagent while adding stability in solution on the synthesizer AND offering strong ability to sulfurize RNA linkages. Sulfurizing Reagent II is available in powder form and as a stable solution.
| 40-4036-10 |
1g |
50.00 |
| |
40-4036-20 |
2g |
100.00 |
| 40-4036-A1 |
each |
10.00 |
| 40-4036-A2 |
each |
10.00 |
| 40-4036-C1 |
each |
15.00 |
| 40-4036-C2 |
each |
15.00 |
| 40-4036-C3 |
each |
10.00 |
| 40-4036-C4 |
each |
10.00 |
| 40-4036-B1 |
each |
10.00 |
| 40-4037-10 |
1g |
50.00 |
| (Dissolve at a concentration of 1g/100mL to form an approximate 0.05M solution) |
40-4037-20 |
2g |
100.00 |
| 40-4137-51 |
100ml |
100.00 |
| |
40-4137-52 |
200mL |
200.00 |
| |
40-4137-57 |
450mL |
450.00 |
|
|
 |
Sulfurizing Reagent II |
 |
Sulfurizing Reagent |
|
http://www.glenres.com/Catalog/backbone.html
|
|